Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy ModelsEstelle Daudigeos‐Dubus, Birgit Geoerger|PLoS ONE|2015Cited by 57
Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumorsEstelle Daudigeos‐Dubus, Birgit Geoerger|International Journal of Oncology|2016Cited by 44